244 related articles for article (PubMed ID: 36757814)
21. Mutations in
Willems AP; Gundogdu M; Kempers MJE; Giltay JC; Pfundt R; Elferink M; Loza BF; Fuijkschot J; Ferenbach AT; van Gassen KLI; van Aalten DMF; Lefeber DJ
J Biol Chem; 2017 Jul; 292(30):12621-12631. PubMed ID: 28584052
[No Abstract] [Full Text] [Related]
22. Hsp90 regulates O-linked β-N-acetylglucosamine transferase: a novel mechanism of modulation of protein O-linked β-N-acetylglucosamine modification in endothelial cells.
Zhang F; Snead CM; Catravas JD
Am J Physiol Cell Physiol; 2012 Jun; 302(12):C1786-96. PubMed ID: 22496241
[TBL] [Abstract][Full Text] [Related]
23. Antibodies and activity measurements for the detection of O-GlcNAc transferase and assay of its substrate, UDP-GlcNAc.
Lefebvre T; Drougat L; Olivier-Van Stichelen S; Michalski JC; Vercoutter-Edouart AS
Methods Mol Biol; 2013; 1022():147-59. PubMed ID: 23765660
[TBL] [Abstract][Full Text] [Related]
24. Impact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy.
Kim G; Cao L; Reece EA; Zhao Z
Sci Rep; 2017 Sep; 7(1):11107. PubMed ID: 28894244
[TBL] [Abstract][Full Text] [Related]
25. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
[TBL] [Abstract][Full Text] [Related]
26.
Zhang J; Wei K; Qu W; Wang M; Zhu Q; Dong X; Huang X; Yi W; Xu S; Li X
J Neurosci; 2023 Jun; 43(25):4559-4579. PubMed ID: 37225434
[TBL] [Abstract][Full Text] [Related]
27. Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice.
Ida S; Morino K; Sekine O; Ohashi N; Kume S; Chano T; Iwasaki K; Harada N; Inagaki N; Ugi S; Maegawa H
Diabetologia; 2017 Sep; 60(9):1761-1769. PubMed ID: 28642969
[TBL] [Abstract][Full Text] [Related]
28. Undetectable histone O-GlcNAcylation in mammalian cells.
Gagnon J; Daou S; Zamorano N; Iannantuono NV; Hammond-Martel I; Mashtalir N; Bonneil E; Wurtele H; Thibault P; Affar el B
Epigenetics; 2015; 10(8):677-91. PubMed ID: 26075789
[TBL] [Abstract][Full Text] [Related]
29. O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart.
Watson LJ; Facundo HT; Ngoh GA; Ameen M; Brainard RE; Lemma KM; Long BW; Prabhu SD; Xuan YT; Jones SP
Proc Natl Acad Sci U S A; 2010 Oct; 107(41):17797-802. PubMed ID: 20876116
[TBL] [Abstract][Full Text] [Related]
30. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
[TBL] [Abstract][Full Text] [Related]
31. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
32. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
Goldberg H; Whiteside C; Fantus IG
Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
[TBL] [Abstract][Full Text] [Related]
33. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
[TBL] [Abstract][Full Text] [Related]
34. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
35. Lack of O-GlcNAcylation enhances exercise-dependent glucose utilization potentially through AMP-activated protein kinase activation in skeletal muscle.
Murata K; Morino K; Ida S; Ohashi N; Lemecha M; Park SY; Ishikado A; Kume S; Choi CS; Sekine O; Ugi S; Maegawa H
Biochem Biophys Res Commun; 2018 Jan; 495(2):2098-2104. PubMed ID: 29253568
[TBL] [Abstract][Full Text] [Related]
36. O-GlcNAcylation regulates EZH2 protein stability and function.
Chu CS; Lo PW; Yeh YH; Hsu PH; Peng SH; Teng YC; Kang ML; Wong CH; Juan LJ
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1355-60. PubMed ID: 24474760
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of protein phosphatase 2A by okadaic acid induces translocation of nucleocytoplasmic O-GlcNAc transferase.
Sitosari H; Morimoto I; Weng Y; Zheng Y; Fukuhara Y; Ikegame M; Okamura H
Biochem Biophys Res Commun; 2023 Feb; 646():50-55. PubMed ID: 36706705
[TBL] [Abstract][Full Text] [Related]
38. O-linked β-N-acetylglucosamine modification of proteins is essential for foot process maturation and survival in podocytes.
Ono S; Kume S; Yasuda-Yamahara M; Yamahara K; Takeda N; Chin-Kanasaki M; Araki H; Sekine O; Yokoi H; Mukoyama M; Uzu T; Araki SI; Maegawa H
Nephrol Dial Transplant; 2017 Sep; 32(9):1477-1487. PubMed ID: 28339907
[TBL] [Abstract][Full Text] [Related]
39. O-GlcNAcylation of TRIM29 and OGT translation forms a feedback loop to promote adaptive response of PDAC cells to glucose deficiency.
Zhao FY; Chen X; Wang JM; Yuan Y; Li C; Sun J; Wang HQ
Cell Oncol (Dordr); 2024 Jun; 47(3):1025-1041. PubMed ID: 38345749
[TBL] [Abstract][Full Text] [Related]
40. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
